Third Vaccine to arrive in India on June

It has a proven efficacy rate of 91.5 percent, which is the highest after Moderna and Pfizer-BioNTech’s vaccine.

Amidst the rise of corona virus in the country, Dr Reddy's Laboratories is expecting to rollout the Sputnik-V, COVID-19 vaccine by May-end or early June. Sputnik-V has been developed by the Russian state-backed Gamaleya Research Institute of Epidemiology and Microbiology. Dr Reddy's has tied up with the Russian Direct Investment Fund (RDIF) and sell the jab in India.

The company's co-chairman and MD, GV Prasad, said on April 20 "We are doing our best to accelerate the import. We hope to get products launched in this quarter itself. We have worked out the cold chain and logistics are in place. We are talking to RDIF to accelerate the shipments here.”

The Indian drug regulator had approved the Russian-made vaccine for emergency use earlier this month.The vaccine needs to be stored at 2-8 degrees Celsius. It has a proven efficacy rate of 91.5 percent, which is the highest after Modernaand Pfizer-BioNTech’s vaccine.

The government was considering allowing private entities to import approved vaccines for sale on the open market without government intervention. They could also be given the freedom to set pricing. The Indian government currently regulates the sale and purchase of all COVID-19 shots in the country.

The government has also decided to open vaccinations for all adults from May 1.

India Scanner News Network

Leave a comment